ABSTRACT Nineteen fluoroquinolone-resistant Escherichia coli strains were isolated from poultry litter. Sixteen of the 19 strains were serotyped to groups 6, 8, 53, 56, 153, and 174. Three strains were not serotyped to any known group. All isolates were resistant to multiple antibiotics. Most strains were resistant to gentamicin, kanamycin, chloramphenicol, and streptomycin. Ribotyping of the multidrug-resistant isolates with restriction enzyme PvuII showed 5 different ribogroups, suggesting independent development of resistance instead of clonal spread. Quinolone resistance was associated with mutations of the quinolone resistance-determining region (QRDR) of the gyr A gene in all cases. To determine the incidence of gyr A mutations in fluoroquinolone-resistant E. coli isolates, a rapid PCR-based assay was used by
INTRODUCTION
Escherichia coli is a commensal bacterium of the gut microflora of the chicken. Some serotypes are pathogenic if they are inhaled into the respiratory tract, and these are probably the most frequent and economically significant cause of bacterial diseases, particularly colisepticemia, in broiler chickens (Goodwin et al., 1993; Gross, 1994; Amara et al., 1995; Blanco et al., 1997) . The most common form of colisepticemia is characterized by an infection of the air sacs. Clinical signs of colisepticemia include reduction in food consumption, listlessness, ruffled feathers, labored rapid breathing, and a characteristic "snicking" (Wray et al., 1996) . Fluoroquinolones are broad-spectrum antimicrobial agents effective in the treatment of a wide range of infections (Medders et al., 1998) . Enrofloxacin, danofloxacin, and sarafloxacin are synthetic drugs belonging to the fluoroquinolone class of compounds (Hooper, 1998) .
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amplifying a 164-bp region of the gyr A gene containing the mutation sites followed by digestion of the PCR product with restriction enzyme HinfI. A higher level of resistance to ciprofloxacin [minimum inhibitory concentration (MIC) >4 µg] was associated with double mutations, but the mutants with a low level of resistance (MIC <2 µg) had only a single mutation. Those strains that were ciprofloxacin-resistant (MIC <2 µg) had a single mutation of a C-to-T transition at position 248 (Ser 83→Leu) or a G-to-A transition at position 259 (Asp 87→Asn). The ciprofloxacin-resistant (MIC >4 µg) isolates had mutations at both positions. Fluoroquinolone resistance was present among different serotypes and ribotypes, and drug resistance profiles suggest that the incidence of resistance does not indicate a clonal population in avian E. coli.
Mechanisms of resistance to fluoroquinolones include alterations in DNA gyrase and topoisomerase IV and decreased intracellular accumulation of the antimicrobial agent due to modifications of membrane proteins (Piddock and Wise, 1989) . Two fluoroquinolones, sarafloxacin and enrofloxacin, were approved in 1995 and 1996 in the United States for veterinary use to control morbidity and mortality associated with E. coli-related colibacillosis infections (Medders et al., 1998) . Use of this class of antibiotics may result in the selection of fluoroquinolone-resistant microflora (Perez-Trallero et al., 1993; Cometta et al., 1994; Kern et al., 1994; Medders et al., 1998; White et al., 2000) .
Clinical resistance to fluoroquinolones in E. coli is mostly associated with mutations located in the quinolone resistance-determining region (QRDR) of the gyr A gene (Yoshida et al., 1990; Heisig 1996) . Amino acid changes at Ser-83 and Asp-87 in gyr A have most frequently been found in E. coli mutant strains and in clinical isolates exhibiting high levels of resistance to nalidixic acid and fluoroquinolones (Hallett and Maxwell, 1991; Everett et al., 1996; Heisig, 1996) . Resistance to quinolones Abbreviation Key: MIC = minimum inhibitory concentration; QRDR = quinolone resistance-determining region may also be due to mutation in the B subunit (gyrB) of DNA gyrase and in the parC-encoded subunit of topoisomerase IV (Yoshida et al., 1990; Everett et al., 1996; Heisig 1996) . The prevalence of fluoroquinolone-resistant E. coli in poultry ecosystems must be characterized because drug-resistant E. coli may play a role in the transfer of resistance to its clinical counterparts and may play a role in complicating the clinical treatment of E. coli infections in humans. In this study, we report the isolation and molecular characterization of high-level fluoroquinoloneresistant E. coli from broiler chicken litter.
MATERIALS AND METHODS

Bacterial Strains
Fluoroquinolone-resistant E. coli isolates were isolated in 2002 and 2003 from 200 litter samples collected from Arkansas chicken and turkey farms. For the isolation of quinolone-resistant E. coli, 25 g of litter was mixed in 225 mL of sterile lactose broth and incubated overnight at 35°C. This mixture (1 mL) was then added to 10 mL of selenite cystine 2 and tetrathionate broth 2 and incubated overnight at 35°C. The next day, bacteria were streaked on bismuth sulfite, xylose lysine desoxycholate, 2 and MacConkey agar plates.
2 Suspected E. coli colonies were confirmed by biochemical methods and PCR.
Serotyping and Antimicrobial Susceptibility Testing
All E. coli strains were serotyped at The Pennsylvania State University, Gastroenteric Disease Center, University Park, PA. Susceptibility testing of E. coli isolates was performed by a disk diffusion method (Bauer et al., 1966). 3 Overnight cultures, grown on trypticase soy broth (optical density adjusted to MacFarland 0.5), were spread evenly on Mueller-Hinton agar plates. Each E. coli isolate was tested with multiple antibiotics (Table 1 ). The plates were incubated at 37°C for 24 h. The zones of inhibition were measured and interpreted as resistant or sensitive according to the manufacturer's guidelines.
3 Ciprofloxacin minimum inhibitory concentration (MIC) values were determined by an Epsilometer test 4 (E-test).
Automated Ribotyping
Automated ribotyping was performed using the RiboPrinter microbial characterization system 5 according to the manufacturer's instructions. Briefly, a few colonies of 2 Remel, Lenexa, KS. overnight-grown E. coli were picked from fresh individual tryptic soy agar plates, suspended in sample buffer, and heat-treated at 80°C for 20 min to inhibit endogenous DNA degradation enzymes. Lysis buffer was added to the samples before they were loaded into the RiboPrinter. Within the instrument, bacterial DNA was digested with PvuII restriction enzyme, 6 and fragments were separated by agarose gel electrophoresis, transferred directly to nylon membranes, and hybridized with a chemiluminescent labeled probe containing the rRNA operon (rrnB) from E. coli (Bruce, 1996) . The pattern of restriction fragments hybridized and emitting chemiluminescence was then converted to digital information by a charge-coupleddevice camera and stored in the RiboPrinter database. The riboprint pattern for each isolate was compared with the patterns produced for all the other isolates using the same restriction enzyme. These isolate-to-isolate comparisons were used to define ribogroups (Bruce, 1996) .
Detection of Mutations at Ser-83 and Asp-87 in the gyr A Gene
A PCR method that involves the introduction of an artificial restriction enzyme cleavage site into the PCR product by using a primer-specified restriction site modification method and restriction enzyme digestion of the PCR product, detected mutations at Ser-83 and Asp-87 in gyr A DNA fragments including the QRDR of gyr A were amplified from chromosomal DNA with the primers EC-GYRA-A (5′-CGCGTACTTTACGCCATGAACGTA-3′) and EC-GYRA-HinfI (5′-ATATAACGCAGCGA-GAATGGCTGCGCCATGCGGACAATCGAC-3′). The sense primer, EC-GYRA-A, was identical to nucleotide positions 139 to 162 of the E. coli gyrA gene. The antisense primer, EC-GYRA-HinfI (nucleotides 261 to 302), was located in the vicinity of the mutation site at Asp-87 with one mismatched nucleotide to create a new HinfI cleavage site in the region including Asp-87. The amplification reaction was carried out in a DNA thermal cycler.
7 These primers produced a 164-bp DNA fragment that was purified by the QIAGEN PCR cleanup kit. 8 The purified PCR product was digested with HinfI 6 and electrophoresed on a 3% agarose gel, stained with ethidium bromide, and visualized with a UV transilluminator.
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RESULTS AND DISCUSSION
Isolation, Identification, and Antibiotic Profiles of E. coli Isolates from Chicken Litter Samples
Escherichia coli strains were screened for nalidixic acid and ciprofloxacin resistance using a disk diffusion method. Nineteen E. coli isolates resistant to nalidixic acid (30 µg) and ciprofloxacin (5 µg) were further characterized. All strains were resistant to multiple antibiotics (Table 1). However, only 12 of the 19 isolates were resistant to ciprofloxacin by the disk diffusion method (5 µg). To determine the level of resistance to ciprofloxacin, an E- 
2 AM = ampicillin; NA = nalidixic acid; CIP = ciprofloxacin; B = bacitracin; C = chloramphenicol; E = erythromycin; GM = gentamicin; OFX = ofloxacin; ST = streptomycin; SXT = sulfamethaxazole and trimethoprim; TE = tetracycline; K = kanamycin; VA = virginiamycin; NOR = norfloxacin.
test strip was used (Table 2) . Twelve strains were highly resistant to ciprofloxacin (>5 µg) ( Table 2 ). Seven strains were resistant to nalidixic acid (30 µg) and ciprofloxacin (0.125 to 2.5 µg; Table 2 ). These strains are reported as sensitive in Table 1 because the disk contained 5 µg of ciprofloxacin. Two of the strains (#346 and 383) were resistant to 13 different antibiotics (Table 1) . However, the resistance profile of strain #346 was different from strain #383. Strain #346 was sensitive to ampicillin, and strain #383 was resistant. Strain #383 was sensitive to gentamicin, and strain #346 was resistant (Table 1) . Regardless of the strain, all isolates were resistant to bacitra- cin, erythromycin, and vancomycin. Among all fluoroquinolone-resistant isolates, strain #329 was highly resistant (>32 µg) ( Table 2 ). This strain was also resistant to 10 other antibiotics tested, however, it was sensitive to chloramphenicol, kanamycin, streptomycin, and trimethoprim sulfamethoxazole.
Serological Typing
The 17 isolates were grouped into 5 serotype groups, 6, 8, 86, 53w, and 174 (Table 3) . Two strains, #339 and 390, were negative to all standard antisera. These results indicate that fluoroquinolone resistance in these strains is widely distributed in different serotypes. Two strains, 8  EC62  53w  EC329  153  EC330  174  EC331  174  EC334  174  EC335  174  EC339  -EC347  174  EC357  53W  EC361  53W  EC362  53W  EC368  53W  EC383  174  EC384  -EC385  86  EC390  -EC392  6 1 w = weak; − = negative (did not react with any known 180 O antisera).
FIGURE 1.
HinfI restriction fragment length polymorphism: 164-bp products amplified from the chromosomal DNA of Escherichia coli with double mutation of a C-to-T transition at position 248 (Ser-83→Leu) and a G-to-A transition at position 259 (Asp-87→Asn) in gyrA (lanes 1 to 3, 7 to 11); strain with no mutations (lane 5); strains with a single Cto-T transition at position 248 (Ser-83→Leu) (lanes 6, 12, and 13); and a strain with a single G-to-A transition at position 259 (Asp-87→Asn) (lane 4).
#346 and 383, which were highly resistant to ciprofloxacin, belonged to type 174.
Detection of Mutations in QRDR of gyrA
To determine the quinolone resistance-associated mutations in the gyrA gene, all strains were examined for mutations in gyrA by the method described by Ozeki et al. (1997) . In brief, the gyrA gene mutation at QRDR was examined by amplifying the partial gyrA gene and introduction of an artificial restriction enzyme cleavage site for HinfI (Ozeki et al., 1997) . The wild type strains with no mutation at Ser-83 and Asp-87 produced fragments of 109, 15, and 40 bp, because there was a HinfI site at Ser-83 and one site at Asp-87 that was artificially created by the PCR primer. However, the strains that had mutations at Ser-83 or Asp-87 or both were not digested. When only 2 DNA fragments of 109 and 55 bp were produced, then they had a mutation only at Asp-87. Strains that had a mutation at Ser-83 would produce 124-and 40-bp DNA fragments. Figure 1 shows the agarose gel electrophoretic profile obtained after digestion of wild type and mutant strains with HinfI. The strains that were resistant to ciprofloxacin (>5 µg) showed the double mutation at Ser-83 and Asp-87 (Figure 1, lanes 2 and 3) . However, the strains resistant to ciprofloxacin (<5 µg) had only one mutation at either Ser-83 or Asp-87.
The results of point mutation studies are summarized in Table 2 . The strains with mutations at Ser-83 or Asp-87 or both were highly resistant to nalidixic acid (>30 µg) and strains that lacked these mutations were less resistant (<30 µg). Strains with mutations at Ser-83 and Asp-87 were more resistant to ciprofloxacin and norfloxacin than strains that had a single mutation. All norfloxacin-resistant isolates exhibited cross-resistance to nalidixic acid and ciprofloxacin. These strains belonged to the resistant category for quinolones (Jones et al., 1994) . Ozeki et al. (1997) reported ofloxacin-resistant E. coli that showed cross-resistance to ciprofloxacin and norfloxacin and had mutations at Ser-83 or Asp-87 or both.
Ribotype Analysis
The ribotype patterns of fluoroquinolone-resistant E. coli strains used in this study are shown in Figure 2 . Two restriction enzymes, BamHI and PvuII, were used initially to see which enzyme could better distinguish fluoroquinolone-resistant E. coli strains. There was better discrimination among the isolates with PvuII than with BamHI. All 19 strains were grouped into 5 subgroups by PvuII. Strain #55 belonged to ribogroup S1, #203 belonged to ribogroup S3, and #329 belonged to ribogroup S4. Fourteen strains belonged to ribotype group S2 and S5 ( Figure  2 ). Seven strains highly resistant to ciprofloxacin (>16 µg) belonged to ribogroup S5 (Figure 2 ). However, #329 that was also highly resistant to ciprofloxacin (>16 µg), was in ribogroup S4. These data indicate that avian E. coli strains that are resistant to fluoroquinolones can be discriminated by ribotyping. The data also suggest individual development of resistance in most isolates rather than clonal selection by horizontal transfer. Pulsed-field gel electrophoretic analysis was unsuccessful due to degradation of DNA (data not shown). The association of fluoroquinolone-resistant avian E. coli isolates among multiple ribogroups indicates a genetically diverse population and suggests that fluoroquinolone resistance has appeared independently and is not due to the emergence of particularly resistant clones.
Our study clearly demonstrates that in E. coli strains, mutations in gyrA, particularly those at Ser-83 and Asp-87, are associated with decreased susceptibility to fluoroquinolones and that the accumulation of strains with mutations at these codons is correlated with an increase in fluoroquinolone resistance. Heisig et al. (1996) have shown that the E. coli strains with a double mutation can be selected in vitro from quinolone-susceptible E. coli strains by multistep exposure to fluoroquinolones, and the exposure of strains with a single mutation in vitro. The increase in the incidence of strains with a single mutation in the gyrA gene might be an indicator of a further increase in the incidence of strains with clinically significant resistance to fluoroquinolones. Therefore, it is important to conduct periodic surveillance of susceptibility of the isolates of avian E. coli and to monitor the percentage of the isolates that harbor quinolone resistance-associated mutations in the gyrA gene. There is much evidence that suggests that antimicrobial use in veterinary medicine may select for antimicrobial resistance in enteric pathogenic bacteria (E. coli, Salmonella spp., and Campylobacter spp.) (Gaunt and Piddock, 1996; Nawaz et al., 2003) . This has led to increased pressure to limit fluoroquinolones in animals to preserve the value of these antibiotics in the treatment of human infections (Cometta et al., 1994) .
In conclusion, this study demonstrates that fluoroquinolone-resistant avian E. coli isolates represent serologically and genetically diverse populations of various subgroups. The study also suggests that fluoroquinolone resistance has appeared among independent populations and was not due to the spread or selection of particular resistant clonal genotypes.
